PUBLISHER: Grand View Research | PRODUCT CODE: 1611041
PUBLISHER: Grand View Research | PRODUCT CODE: 1611041
The global intravenous catheters market size is estimated to reach USD 13.07 billion by 2030, registering a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising R&D investments for risk free IV catheter products, increasing demand for disposable IV catheters, and increasing demand for antimicrobial IV catheters are the major driving factors accelerating the industry growth. Novel product launch, increasing mergers and acquisition among the industry key players, and the rising demand for specialized IV catheters for specific patient population based on age group are key contributors to the market growth.
The industry key players are involved in manufacturing novel IV catheter devices which also enhance the product portfolio. Launching new products is essential for transforming the market, offering novel strategies, and addressing unmet needs in patient care. With the goal of improving patient outcomes and streamlining healthcare procedures, these innovative products frequently combine cutting-edge technologies, increased safety measures, and enhanced functionality.
In November 2023, BD launched new needle-free blood collection equipment that is suitable with integrated catheters. The U.S. FDA has granted the PIVO (Peripherally Inserted Vascular Output device) Needle-Free Blood Collection device received 510(k) approval. The design developments of the devices enable it to be the first and only needle-free blood collection device that is compatible with both integrated and long peripheral intravenous catheters, such as the NexivaTM closed intravenous catheter system with NearPortTM intravenous access. This enhances the PIVO functionality that has been provided since 2017 with conventional short peripheral IV catheters.